Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma

Detalles Bibliográficos
Autores principales: Laino, Antonia, Shepherd, Benjamin, Atkinson, Victoria, Fu, Hong, Soyer, H. Peter, Schaider, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180233/
https://www.ncbi.nlm.nih.gov/pubmed/30320196
http://dx.doi.org/10.1016/j.jdcr.2018.06.024
_version_ 1783362159012478976
author Laino, Antonia
Shepherd, Benjamin
Atkinson, Victoria
Fu, Hong
Soyer, H. Peter
Schaider, Helmut
author_facet Laino, Antonia
Shepherd, Benjamin
Atkinson, Victoria
Fu, Hong
Soyer, H. Peter
Schaider, Helmut
author_sort Laino, Antonia
collection PubMed
description
format Online
Article
Text
id pubmed-6180233
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61802332018-10-12 Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma Laino, Antonia Shepherd, Benjamin Atkinson, Victoria Fu, Hong Soyer, H. Peter Schaider, Helmut JAAD Case Rep Case Report Elsevier 2018-10-10 /pmc/articles/PMC6180233/ /pubmed/30320196 http://dx.doi.org/10.1016/j.jdcr.2018.06.024 Text en © 2018 Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Laino, Antonia
Shepherd, Benjamin
Atkinson, Victoria
Fu, Hong
Soyer, H. Peter
Schaider, Helmut
Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma
title Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma
title_full Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma
title_fullStr Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma
title_full_unstemmed Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma
title_short Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma
title_sort tumoral melanosis associated with combined braf/mek inhibition (dabrafenib/trametinib) in metastatic melanoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180233/
https://www.ncbi.nlm.nih.gov/pubmed/30320196
http://dx.doi.org/10.1016/j.jdcr.2018.06.024
work_keys_str_mv AT lainoantonia tumoralmelanosisassociatedwithcombinedbrafmekinhibitiondabrafenibtrametinibinmetastaticmelanoma
AT shepherdbenjamin tumoralmelanosisassociatedwithcombinedbrafmekinhibitiondabrafenibtrametinibinmetastaticmelanoma
AT atkinsonvictoria tumoralmelanosisassociatedwithcombinedbrafmekinhibitiondabrafenibtrametinibinmetastaticmelanoma
AT fuhong tumoralmelanosisassociatedwithcombinedbrafmekinhibitiondabrafenibtrametinibinmetastaticmelanoma
AT soyerhpeter tumoralmelanosisassociatedwithcombinedbrafmekinhibitiondabrafenibtrametinibinmetastaticmelanoma
AT schaiderhelmut tumoralmelanosisassociatedwithcombinedbrafmekinhibitiondabrafenibtrametinibinmetastaticmelanoma

Ejemplares similares